血管紧张素转换酶基因2多态性与云南佤族人群原发性高血压的关系

刘师节, 何燕, 杨文慧, 等. 血管紧张素转换酶基因2多态性与云南佤族人群原发性高血压的关系[J]. 临床心血管病杂志, 2018, 34(10): 970-976. doi: 10.13201/j.issn.1001-1439.2018.10.008
引用本文: 刘师节, 何燕, 杨文慧, 等. 血管紧张素转换酶基因2多态性与云南佤族人群原发性高血压的关系[J]. 临床心血管病杂志, 2018, 34(10): 970-976. doi: 10.13201/j.issn.1001-1439.2018.10.008
LIU Shijie, HE Yan, YANG Wenhui, et al. The correlation research of angiotensin converting enzyme 2 gene polymorphism and essential hypertension in Wa minorities in Yunnan province[J]. J Clin Cardiol, 2018, 34(10): 970-976. doi: 10.13201/j.issn.1001-1439.2018.10.008
Citation: LIU Shijie, HE Yan, YANG Wenhui, et al. The correlation research of angiotensin converting enzyme 2 gene polymorphism and essential hypertension in Wa minorities in Yunnan province[J]. J Clin Cardiol, 2018, 34(10): 970-976. doi: 10.13201/j.issn.1001-1439.2018.10.008

血管紧张素转换酶基因2多态性与云南佤族人群原发性高血压的关系

  • 基金项目:

    云南省重大科技专项计划 (No:2017ZF027)

    云南省科技厅昆医联合专项 (No:2012FB098, 2013FZ286)

    昆明市卫生科技人才培养暨内设研究 (No:2016SWJG)

详细信息
    通讯作者: 杨莉,E-mail:13330466619@189.cn
  • 中图分类号: R544.1

The correlation research of angiotensin converting enzyme 2 gene polymorphism and essential hypertension in Wa minorities in Yunnan province

More Information
  • 目的:探讨血管紧张素转换酶 (ACE2) 基因多态性与佤族原发性高血压 (EH) 人群的关系。方法:应用SnapShot技术检测了260例云南佤族EH患者及290名正常血压对照者ACE2基因20个多态位点基因型 (rs1514283、rs1514282、rs2074192、rs233575、rs714205、rs4240157、rs4646176、rs4646174、rs879922、rs4646156、rs4646155、rs4646188、rs4646140、rs2158083、rs2285666、rs2106809、rs1978124、rs6632677、rs2301692、rs2306193), 应用χ2检验比较组间基因型及等位基因频率, 运用Hardy-Weinberg平衡检验后, 用Haploview软件进行连锁不平衡分析, 并用SHEsis软件进行单倍体构建, 从而探讨ACE2基因多态性与佤族人群高血压的相关关系。结果:① 本次研究在20个候选位点发现5个多态位点, 这5个位点均存在连锁不平衡现象, 但部分位点不能在以后的研究中相互代替。② rs2285666位点、rs714205位点的CC基因型及C等位基因是佤族女性EH的保护因素 (P<0.05, OR<1), 而rs2285666位点的T等位基因、rs714205位点的G等位基因是佤族女性EH患病的致病因素 (P<0.05, OR>1);在佤族男性群体中并没有发现具有统计学意义的基因型及等位基因 (P>0.05)。③ 对ACE2的5个多态性位点构建单倍型, 未发现具有统计学意义的单倍型, 说明这5个位点组成的单倍型与佤族EH均无关联。结论:ACE2基因中rs2285666及rs714205这两个多态位点可能与佤族女性EH相关。
  • 加载中
  • [1]

    Zhong JC, Basu R, Guo D, et al.Angiotensin converting enzyme 2suppresses pathological hypertrophy, myocardial fibrosis and cardiac dysfunction[J].Circulation, 2010, 122 (7):717-728.

    [2]

    Tan Z, Wu J, Ma H, et al.Regulation of angiotensinconverting enzyme 2and Masreceptor by Ang- (1-7) in heart and kidney of spontaneously hypertensive rats[J].J Renin Angiotensin Aldosterone Sys, 2011, 12 (4):413-419.

    [3]

    Yang S, Liu S, Wang Y, et al.High blood pressure in Chinese ethnic minorities:report from rural Yunnan province[J].Am J Hypertens, 2011, 24 (11):1209-1214.

    [4]

    Ferreira AJ, Shenoy V, Qi Y, et al.Angiotensin-converting enzyme 2activation protects against hypertension-induced cardiac fibrosis involving extracellular signal regulated kinases[J].Exp Physiol, 2011, 96 (2):287-294.

    [5]

    Burrell LM, Harrap SB, Velkoska E, et al.TheACE2 gene:its potential as a functional candidate for cardiovascular disease[J].Clin Sci (Lond), 2013, 124 (1):65-76.

    [6]

    潘小进, 崔爱红, 李健.原发性高血压血管紧张素转换酶2基因多态性与胰岛素抵抗的关系[J].临床心血管病杂志, 2015, 31 (7):766-768.

    [7]

    Ma TK, Kam KK, Yan BP, et al.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases:current status[J].Br J Pharmacol, 2010, 160 (11):1273-1292.

    [8]

    Santos RA, Angiotensin- (1-7)[J].Hypertension, 2014, 63 (10):1138-1147.

    [9]

    王利红, 纪禄风, 石向慧, 等.我国不同地区高血压病易感基因研究现状[J].临床心血管病杂志, 2017, 33 (6):605-608.

    [10]

    Wu J, Cheng X, Qiu L, et al.Prevalence and clustering of major cardiovascular risk factors in china:a recent cross-sectional survey[J].Medicine (Baltimore), 2016, 95 (10):e2712.

    [11]

    Chen L, Zong Y, Wei T, et al.Prevalence, awareness, medication, control, and risk factorsassociated with hypertension in Yi ethnic group aged 50years and over in rural China:the Yunnan minority eye study[J].BMC Public Health, 2015, 15 (3):383-385.

    [12]

    Xie RB, Liao PJ, Yin RX, et al.Prevalence of hypertension and associated risk factors in Chinese Jing compared with Mulao populations[J].J Int Med Res, 2015, 43 (6):819-833.

    [13]

    Cai W, Yin L, Cheng J, et al.Relationship between the single nucleotide polymorphisms ofβ?-adrenergic receptor 5'-regulatory region and essential hypertension in Chinese Kazakh ethnic minority group[J].Int J Clin Exp Pathol, 2015, 8 (7):8358-8366.

    [14]

    Barrington DS, Adeyemo AA, Rotimi CN.Childhood family living arrangements and blood pressure in black men:the Howard University Family Study[J].Hypertension, 2014, 63 (1):48-53.

    [15]

    Carter BL, Coffey CS, Ardery G, et al.Cluster-randomized trial of aphysician/pharmacist collaborative model to improve blood pressure control[J].Circ Cardiovasc Qual Outcomes, 2015, 8 (3):235-243.

    [16]

    Gutierrez J, Williams OA.A decade of racial and ethnic stroke disparities in the United States[J].Neurology, 2014, 82 (12):1080-1082.

    [17]

    Agyemang C, Snijder MB, Adjei DN, et al.Ethnic Disparities in CKD in the Netherlands:The Healthy Life in an Urban Setting (HELIUS) Study[J].Am J Kidney Dis, 2016, 67 (3):391-399.

    [18]

    Woo D, Rosand J, Kidwell C.The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol[J].Stroke, 2013, 44 (10):e120-125.

    [19]

    Martin L, Oepen J, Reinehr T, et al.Ethnicity and cardiovascular risk factors:evaluation of 40, 921normalweight, overweight or obese children and adolescents living in Central Europe[J].Int J Obes (Lond), 2015, 39 (1):45-51.

    [20]

    Agyemang C, Kieft S, Snijder MB, et al.Hypertension control in a large multi-ethnic cohort in Amsterdam, The Netherlands:the HELIUS study[J].Int J Cardiol, 2015, 183 (2):180-189.

    [21]

    Yi SS, Tabaei BP, Angell SY, et al.Self-blood pressure monitoring in an urban, ethnically diverse population:a randomized clinical trial utilizing the electronic health record[J].Circ Cardiovasc Qual Outcomes, 2015, 8 (2):138-145.

    [22]

    Epstein EJ, Osman JL, Cohen HW, et al.Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1diabetes[J].Diabetes Care, 2013, 36 (8):2280-2286.

    [23]

    Yang M, Zhao J, Xing L, et al.The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk:A meta-analysis involving14, 122 patients[J].J Renin Angiotensin Aldosterone Syst, 2015, 16 (4):1240-1244.

    [24]

    Yi L, Gu YH, Wang XL, et al.Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China[J].J Int Med Res, 2006, 34 (3):272-283.

  • 加载中
计量
  • 文章访问数:  210
  • PDF下载数:  168
  • 施引文献:  0
出版历程
收稿日期:  2018-05-23

目录